These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20041151)

  • 1. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.
    Yang J; Pospisil R; Ray S; Milton J; Mage RG
    PLoS One; 2009 Dec; 4(12):e8494. PubMed ID: 20041151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
    Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
    Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
    Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic contributions to the autoantibody profile in a rabbit model of Systemic Lupus Erythematosus (SLE).
    Puliyath N; Ray S; Milton J; Mage RG
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):251-67. PubMed ID: 18602165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
    Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
    Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
    Du SW; Jacobs HM; Arkatkar T; Rawlings DJ; Jackson SW
    J Immunol; 2018 Dec; 201(11):3258-3268. PubMed ID: 30373855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of BAFF and BR3 in patients with systemic lupus erythematosus.
    Duan JH; Jiang Y; Mu H; Tang ZQ
    Braz J Med Biol Res; 2016 Mar; 49(3):. PubMed ID: 26840704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
    López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
    J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
    Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
    Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
    Lin Z; Dan-Rong Y; Xiao-Qing T; Hao W; Hong-Lian G; Xian-Tao K; Ren-Qian Z; Jiyu L
    J Clin Lab Anal; 2007; 21(3):183-7. PubMed ID: 17506477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
    Eslami M; Schuepbach-Mallepell S; Diana D; Willen L; Kowalczyk-Quintas C; Desponds C; Peter B; Vigolo M; Renevey F; Donzé O; Luther SA; Yalkinoglu Ö; Alouche N; Schneider P
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2404309121. PubMed ID: 38990948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
    Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
    Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
    Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
    Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.